• About Us
    • Awards
    • Careers
    • Executive Board and Staff
    • Membership Information
    • News Room
    • Donate to APHA
    • Governance
    • Calendar
    • Public Health Links
    • Social Media
    • Contact APHA
  • Advocacy & Policy
    • Advocacy Activities
    • Advocacy Tips
    • Fellowship
    • Health Reform
    • Healthiest Nation in One Generation
    • Policy Statements
    • Priorities
    • Reports, Issue Briefs, Fact Sheets and Webinars
    • Take Action
  • APHA Meetings
    • Highlights
    • Schedule and Online Program
    • Exposition
    • Presenter Information
    • Registration
    • Housing
    • Travel
    • Continuing Education
    • Onsite Services
    • Accessibility
    • Frequently Asked Questions
    • Social Media
    • Past & Future Annual Meetings
    • Contact
  • Community
  • Member Groups & Affiliates
    • Sections
    • Special Primary Interest Groups
    • Section & SPIG Newsletters
    • State Affiliates
    • Forums
    • Caucuses
    • Student Assembly
  • Programs
    • Center for Professional Development
    • Environmental Public Health
    • Policy Capacity Building Assistance
    • Get Ready Campaign
    • Global Health
    • National Public Health Week
    • Partnerships
    • Quality Improvement
    • School, Health and Education
  • Publications & Advertising
    • The Nation's Health
    • Advertising
    • American Journal of Public Health
    • Books & Other Media
    • Essential Public Health
    • Publications Contact
    • Inside Public Health
    • Public Health Newswire
APHA American Public Health Association
Shop
Shop		     Donate
Donate		     Join/Renew
Join/Renew
 
Advanced Search
Advocacy & Policy

In This Section

Overview
Legislative Action
Other Resources
Summaries of Bills of Legislation
APHA Home » Advocacy & Policy » Advocacy Archive » Medicare Prescription Drug » Other Resources » Analyses of Medicare Prescription Drug Benefit

Analyses of Medicare Prescription Drug Benefit

  • The New Medicare Drug Benefit: Potential Effects of Pharmacy Management Tools on Access to Medications (Kaiser Family Foundation, June 2004)
  • The New Medicare Prescription Drug Law: Issues for Dual Eligibles with Disabilities and Serious Conditions (Kaiser Family Foundation, June 2004)
  • Doughnut Holes and Price Controls (Health Affairs, July 2004)
  • Closing the Doughnut Hole: No Easy Answers (Health Affairs, July 2004)
  • A Detailed Description of CBO's Cost Estimate for the Medicare Prescription Drug Benefit (CBO, July 2004)

Related Links

  • APHA Condemns House for Cutting Medicaid, Urges Conference Committee to Adopt Senate Provisions that Better Protect the Health of Beneficiaries
  • APHA Chides Congress for Its Passage of Billions in Cuts to Medicaid and Inadequate Investment in Public Health Programs
  • APHA Supports Medicaid Commission’s Call for Responsible Prescription Drug Pricing but Warns Against Co-Payments
  • Medicare Prescription Drug
  • S. 2328, Pharmaceutical Market Access and Drug Safety Act
  • Prescription Drug Discount Cards: Enrollment and Benefits
 Printer-Friendly Page
800 I Street, NW Washington, DC 20001-3710 (Ph) 202-777-APHA (Fax) 202-777-2534

Privacy Policy | Site Map | A-Z Health Topics | Social Media | E-Mail-A-Friend | Careers

2013 © American Public Health Association